Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.

YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol Psychiatry. 2010 Nov 15; 68(10):903-12.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.